Skip to content
Home - Research - Our research news  - Research feature articles    
Genomics is a leading part of our research
Translational science 
(promoting the research process from discovery to patient related studies) is one of our main priorities.
Professor Jan Tornell, Global Director AstraZeneca
Professor Jan Törnell

ProfessorJan Törnell is Global Director for AstraZeneca Transgenics and Comparative Genomics. In connection with his participation at the PharmaDiscovery 2005 conference in Washington D.C. in May, Professor Törnell was interviewed by the internet-based talk radio programme Science and Society.

In the interview, Professor Törnell talks about speeding up the generation of new important medicines by a direct linking of the research at the lab benches to patients in a way that was not possible only a few years ago.

Dr David Lemberg hosts Science and Society, a programme that discusses innovative science particularly in biotechnology and related industries. This sound file is has been provided courtesy of Science and Society and is published with their written permission.

Listen to the interview  

 Windows MediaReal PlayerQuicktime
Narrowband> Play video > Play video > Play video
Broadband> Play video > Play video > Play video
 Requires Windows Media Player. Download it free from the Windows media websiteopens in a new windowRequires Real Player. Download it free from the Real Player websiteopens in a new windowRequires Quicktime. Download it free from the Quicktime websiteopens in a new window
Transcript & glossary of terms

Published 10 August 2005

AstraZeneca websites
Search
Quick Links
Related article